T2 Heart Mapping in AMI Population for the Prediction of Short Term Major Adverse Cardiovascular Events

Withdrawn before enrolling

Conditions studied: Myocardial Infarction, Acute

In brief

A novel Cardiac MRI sequence, developed by Dr. Maria Altbach (Double Inversion radial fast Spin Echo T2 mapping), has been tested clinically. It demonstrated a high sensitivity to the heart muscle swelling ("edema") in different types of heart injury, including heart attacks. The investigators propose to use T2-Map methodology in patients with acute heart attacks and to compare value of this method with other clinical and imaging parameters in predicting short-term (30 day) clinical outcomes of these patients. If successful, the project will provide an effective risk-stratification tool to identify patients with heart attack as a result of atherosclerotic disease, who require more aggressive therapeutic approach and closer follow-up after initial hospitalization.

Key facts

Study ID

NCT01796743

Run by

University of Arizona

People needed

0

Starts

2013-02-01

Expected to finish

2015-12-01

Last updated by the study team

2017-02-08

Who can join

Age: 18 and older, up to 89. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• between 18 to 89 years old
• diagnosis of Acute MI
• clinically

You may not qualify if…

• contraindications for contrast enhanced CMR
• acute congestive heart failure
• ventricular or atrial arrhythmias
• ongoing chest pain/unstable angina
• ECG changes suggestive of acute/ongoing ischemia
• hypotension with systolic blood pressure <100 mmHg
• severe hypertension despite therapy, with systolic BP>180 mmHg,
• Patients without a telephone number and/or address for follow up
• Patients with severe claustrophobia.
• Vulnerable populations, such as minors, pregnant women, prisoners, or cognitively impaired patients

Where it is running

• University of Arizona — Tucson, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.